NM_002458.3:c.13124C>T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong

The NM_002458.3(MUC5B):​c.13124C>T​(p.Ala4375Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0249 in 1,600,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.026 ( 0 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

2
15

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -7.65

Publications

4 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PM2
Variant has high frequency in the NFE (0.0283) population. However there is too low homozygotes in high coverage region: (expected more than 247, got 0).
BP4
Computational evidence support a benign effect (MetaRNN=0.0036114454).
BP6
Variant 11-1250004-C-T is Benign according to our data. Variant chr11-1250004-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 403191.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.13124C>T p.Ala4375Val missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.13124C>T p.Ala4375Val missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84

Frequencies

GnomAD3 genomes
AF:
0.0145
AC:
2167
AN:
149632
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00345
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00402
Gnomad ASJ
AF:
0.0165
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00564
Gnomad FIN
AF:
0.0428
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0214
Gnomad OTH
AF:
0.0116
GnomAD2 exomes
AF:
0.0188
AC:
4618
AN:
245546
AF XY:
0.0184
show subpopulations
Gnomad AFR exome
AF:
0.00382
Gnomad AMR exome
AF:
0.00285
Gnomad ASJ exome
AF:
0.0198
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0622
Gnomad NFE exome
AF:
0.0243
Gnomad OTH exome
AF:
0.0185
GnomAD4 exome
AF:
0.0259
AC:
37610
AN:
1450250
Hom.:
0
Cov.:
120
AF XY:
0.0253
AC XY:
18246
AN XY:
721362
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00308
AC:
103
AN:
33406
American (AMR)
AF:
0.00419
AC:
187
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
0.0246
AC:
637
AN:
25880
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.00708
AC:
608
AN:
85846
European-Finnish (FIN)
AF:
0.0612
AC:
3194
AN:
52168
Middle Eastern (MID)
AF:
0.00417
AC:
24
AN:
5760
European-Non Finnish (NFE)
AF:
0.0285
AC:
31484
AN:
1103056
Other (OTH)
AF:
0.0229
AC:
1373
AN:
59876
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.264
Heterozygous variant carriers
0
3761
7522
11283
15044
18805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
1204
2408
3612
4816
6020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0145
AC:
2169
AN:
149756
Hom.:
0
Cov.:
32
AF XY:
0.0144
AC XY:
1053
AN XY:
73106
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00344
AC:
142
AN:
41288
American (AMR)
AF:
0.00401
AC:
61
AN:
15204
Ashkenazi Jewish (ASJ)
AF:
0.0165
AC:
56
AN:
3404
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5124
South Asian (SAS)
AF:
0.00564
AC:
27
AN:
4784
European-Finnish (FIN)
AF:
0.0428
AC:
433
AN:
10112
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0214
AC:
1425
AN:
66554
Other (OTH)
AF:
0.0115
AC:
24
AN:
2084
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.294
Heterozygous variant carriers
0
154
307
461
614
768
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0229
Hom.:
0
ESP6500AA
AF:
0.00633
AC:
27
ESP6500EA
AF:
0.0245
AC:
207
ExAC
AF:
0.0264
AC:
3202

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.17
DANN
Benign
0.46
DEOGEN2
Benign
0.027
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.00084
N
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
-7.6
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.29
N
REVEL
Benign
0.032
Sift
Uncertain
0.021
D
Vest4
0.014
ClinPred
0.0063
T
GERP RS
-3.4
Varity_R
0.044
gMVP
0.27
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201748966; hg19: chr11-1271234; COSMIC: COSV71594265; COSMIC: COSV71594265; API